Eclaire is an AI-powered platform designed to revolutionize the clinical trial validation process by automating edit check validation across Electronic Data Capture (EDC) systems like Veeva. By leveraging autonomous agents, Eclaire reduces validation time from the traditional 60-90 days to just 2 days, achieving 99.8% accuracy and significantly lowering operational costs.
Key Features and Functionality:
- EDC System Integration: Seamlessly connects with EDC systems such as Veeva, Medidata, and Oracle Clinical, automatically extracting edit check logic, validation rules, and form designs without disrupting existing infrastructure.
- AI Test Case Generation: Analyzes study specifications to autonomously generate comprehensive test cases covering positive, negative, and edge scenarios, eliminating the need for manual test creation.
- Autonomous Parallel Execution: Executes thousands of test cases simultaneously across the EDC environment, completing in hours what traditionally takes weeks, while maintaining detailed evidence for regulatory compliance.
- Real-time Analytics Dashboard: Provides monitoring of validation progress, test results, and potential issues through an intuitive dashboard, with automatic alerts for failures and tracking of key metrics.
- Automated Documentation: Generates comprehensive validation documentation, including test evidence, traceability matrices, and regulatory-ready reports that meet FDA, EMA, and ICH requirements.
- Self-Healing Test Cases: Utilizes reinforcement learning algorithms to continuously improve test cases based on execution results, adapting to changes in the EDC system and study design.
Primary Value and User Solutions:
Eclaire addresses the inefficiencies and high costs associated with manual edit check validation in clinical trials. By automating this process, it offers:
- Accelerated Study Startup: Reduces study build and validation time from 90 days to just 2 days, enabling earlier patient data collection and faster development timelines.
- Improved Data Quality: Ensures edit checks function correctly from the outset, reducing data queries, protocol deviations, and the need for database corrections during the trial.
- Resource Optimization: Decreases staffing needs from 3-5 Full-Time Equivalents (FTEs) to just 0.5 FTE for edit check validation, allowing teams to focus on higher-value activities.
- Faster Amendment Implementation: Validates protocol amendments within hours instead of weeks, minimizing disruption to ongoing trials and data collection.
- Early Database Lock: Maintains higher data quality throughout the trial, resulting in fewer queries at study close and enabling earlier database lock, faster analysis, and quicker regulatory submission.
- Significant Cost Savings: Achieves an average of $2.4 million in direct cost savings per trial through accelerated timelines, reduced resource requirements, and improved data quality.
By transforming a traditionally tedious and error-prone process into a rapid, autonomous operation, Eclaire empowers clinical trial teams to enhance efficiency, accuracy, and cost-effectiveness in their validation workflows.
